Advertisement
Advertisement

NAYA

N

NAYA Biosciences

0.758
USD
-0.042
-5.25%
Dec 18, 13:48 UTC -5
Open

NAYA Biosciences Profile

About

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.

Info & Links

CEO

Steven Shum

Headquarters

5582 BROADCAST COURT
SARASOTA, FL 34240, UNITED STATES

Auditor

M&K CPAS PLLC

Share holders

191

Employees

30

NAYA Biosciences Statistics

Valuation Measures

Market Capitalization2

3.74M

Enterprise Value

5.43M

Enterprise Value/EBITDA(ttm)

-1.41

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.65

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

38.25%

Operating Margin(ttm)

-119.91%

Profit Margin(ttm)

-120.42%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-458.66%

Return on Assets(ttm)

-41.72%

Income Statement

Revenue(ttm)

5.77M

Revenue Per Share(ttm)

1.48

Gross Profit(ttm)

1.97M

EBITDA(ttm)3

-3.86M

Net Income Available to Common(ttm)

-7.08M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.51

52-Week Change

-57.18%

S&P 500 52-Week Change

27.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.91M

Dividend Yield

0.00%

Float4

4.76M

% Held by Insiders

3.50%

% Held by Institutions

12.02%

Balance Sheet

Total Cash(mrq)

942.90K

Total Cash Per Share(mrq)

0.24

Total Debt(mrq)

2.63M

Total Debt/Equity(mrq)

-12230.23%

Current Ratio(mrq)

0.23%

Quick Ratio(mrq)

0.20%

Book Value Per Share(mrq)

-0.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.61

Free Cash Flow(ytd)

-2.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement